Eiran Gorodeski, MD, MPH
Cardiology-Heart Failure, Cardiology
Accepting New Patients
Schedule an Appointment
First Available: Tuesday, Nov 10
- Associate Professor, CWRU School of Medicine
Eiran Z. Gorodeski, MD, MPH, FACC, FHFSA, is Medical Director of the Advanced Heart Failure & Transplant Center and the James and Angela Hambrick Center for Cardiac Recovery, University Hospitals Harrington Heart & Vascular Institute. He also serves as section head of advanced heart failure in the Division of Cardiovascular Medicine and Associate Professor of Medicine at Case Western Reserve University.
Dr. Gorodeski earned his Bachelor of Arts degree at Brandeis University in Waltham, Massachusetts, graduating magna cum laude. He received his medical doctorate from Case Western Reserve University School of Medicine, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed a Master of Public Health degree with a concentration in quantitative methods at Harvard University. He completed his internship and residency in internal medicine at Massachusetts General Hospital, Boston, Massachusetts and his cardiovascular disease and advanced heart failure and cardiac transplantation training at Cleveland Clinic, Cleveland, Ohio. He was a staff cardiologist at Cleveland Clinic from 2010 to 2019.
Dr. Gorodeski has an interest in the medical management of patients with advanced heart failure, including outpatient, inpatient and critical care. He is a clinical expert in cardiac transplantation and left ventricular assist device (LVAD) management. Dr. Gorodeski has published extensively in areas related to heart failure care transitions and the care of older adults with heart failure. In addition to his clinical and research work, Dr. Gorodeski has significant experience in leadership, management and program building in health care settings.
Dr. Gorodeski is an Associate Editor at the Journal of Cardiac Failure. He is an active participant in several committees at both the Heart Failure Society of America and the American College of Cardiology.
- Advanced Heart Failure and Transplant Cardiology - American Board of Internal Medicine
- Cardiovascular Disease - American Board of Internal Medicine
Fellowship | Heart Failure and Cardiac Transplantation
Heart Failure and Cardiac Transplantation - Cleveland Clinic (2009 - 2010)
Fellowship | Cardiovascular Medicine
Cardiovascular Medicine - Cleveland Clinic (2006 - 2009)
Residency | Internal Medicine
Internal Medicine - Massachusetts General Hospital (2003 - 2006)
Harvard School Of Public Health (2003)
Case Western Reserve University School Of Medicine (2003)
Brandeis University (1997)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Eiran Gorodeski did not disclose any Outside Relationships with Industry.